Manipulation of immune‒vascular crosstalk: new strategies towards cancer treatment

Yang Zhao,Xiangrong Yu,Jia Li
DOI: https://doi.org/10.1016/j.apsb.2020.09.014
IF: 14.903
2020-11-01
Acta Pharmaceutica Sinica B
Abstract:<h2 class="section-title u-h3 u-margin-l-top u-margin-xs-bottom">Asbtract</h2><p>Tumor vasculature is characterized by aberrant structure and function, resulting in immune suppressive profiles of tumor microenvironment through limiting immune cell infiltration into tumors, endogenous immune surveillance and immune cell function. Vascular normalization as a novel therapeutic strategy tends to prune some of the immature blood vessels and fortify the structure and function of the remaining vessels, thus improving immune stimulation and the efficacy of immunotherapy. Interestingly, the presence of "immune‒vascular crosstalk" enables the formation of a positive feedback loop between vascular normalization and immune reprogramming, providing the possibility to develop new cancer therapeutic strategies. The applications of nanomedicine in vascular-targeting therapy in cancer have gained increasing attention due to its specific physical and chemical properties. Here, we reviewed the recent advances of effective routes, especially nanomedicine, for normalizing tumor vasculature. We also summarized the development of enhancing nanoparticle-based anticancer drug delivery <em>via</em> the employment of transcytosis and mimicking immune cell extravasation. This review explores the potential to optimize nanomedicine-based therapeutic strategies as an alternative option for cancer treatment.</p>
pharmacology & pharmacy
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is the immunosuppressive microenvironment problem caused by the abnormal structure and function of tumor blood vessels. This restricts the infiltration of immune cells into the tumor and weakens the endogenous immune surveillance and the function of immune cells. Specifically, the paper explores the use of a blood - vessel normalization strategy to prune some immature blood vessels and strengthen the structure and function of the remaining blood vessels, thereby improving immune stimulation and enhancing the effectiveness of immunotherapy. In addition, the paper also discusses how the existence of "immune - vascular crosstalk" forms a positive - feedback loop between blood - vessel normalization and immune reprogramming, providing the possibility for the development of new cancer treatment strategies. The paper pays special attention to the application of nanomedicine in targeted vascular therapy and strategies for enhancing the delivery of nanoparticle - based anticancer drugs by simulating immune cell extravasation and utilizing transcytosis.